Substituted 6,7 Dihydro 5 H Benzo[7]Annulene Compounds And Their Derivatives, Processes For Their Preparation And Therapeutic Uses Thereof

Sanofi
Application Awaiting Examination App No 202317033956 Chemical

Patent information

IP India · live record
Application number
202317033956
Filing date
15 May 2023
Status
Application Awaiting Examination
Publication number
31/2024
Publication type
INA
Invention field
Chemical

Abstract

The present application relates to compounds of formula (I), or pharmaceutically acceptable salts thereof: wherein R1 and R2 represent hydrogen or deuterium; R3 represents hydrogen, -COOH or -OH; R3' and R3" represent hydrogen, methyl, methoxy, chlorine, fluorine or cyano; R4 and R41 represent hydrogen or fluorine; R5 represents hydrogen, fluorine or (C1-C3)aIkyl; R6 represents phenyl, fused phenyl, bicyclic group comprising 5 to 12 carbon atoms, heteroaryl group comprising 2 to 9 carbon atoms and comprising from 1 to 3 heteroatoms, cycloalkyl group comprising 3 to 7 carbon atoms, (C3-C6)cycloalkyl(C1-C3)alkyl group, 3 to 8 membered-heterocycloalkyl group comprising 1 or 2 heteroatoms, (C1-C6)alkyl, and phenyl(C1-C2)alkyl group; X represents -CH2-, -O- or - S-; Y represents -CH=, -N= or -CR" =, wherein R" represents (C1-C3)alkyl, halogen, cyano, or (C1-C3)fluoroalkyl; R7 represents (C1-C3)aIkyl, halogen atom, cyano, or (C1-C3)fluoroalkyl; R8 represents hydrogen or fluorine; R9 represents hydrogen, (C1-C3)alkyl or a cyclopropyl; n is 0, 1 or 2; and m is 0 or 1. Further disclosed are process for preparing the same, pharmaceutical compositions comprising them as well as said compounds of formula (I) for use as an inhibitor and degrader of estrogen receptors, in particular in the treatment of ovulatory dysfunction, cancer, endometriosis, osteoporosis, benign prostatic hypertrophy or inflammation.

Applicants

1
France
SANOFI 46 avenue de la Grande Armée 75017 PARIS

Inventors

8
France
BERNARDELLI, Patrickc/o Sanofi, Patent Department 54, rue la Boétie 75008 PARIS
France
BIANCIOTTO, Marcc/o Sanofi, Patent Department 54, rue la Boétie 75008 PARIS
France
EL AHMAD, Youssefc/o Sanofi, Patent Department 54, rue la Boétie 75008 PARIS
France
HALLEY, Frankc/o Sanofi, Patent Department 54, rue la Boétie 75008 PARIS
France
MOUGENOT, Patrickc/o Sanofi, Patent Department 54, rue la Boétie 75008 PARIS
France
PETIT, Frédéricc/o Sanofi, Patent Department 54, rue la Boétie 75008 PARIS
France
SLOWINSKI, Franckc/o Sanofi, Patent Department 54, rue la Boétie 75008 PARIS
France
TERRIER, Corinnec/o Sanofi, Patent Department 54, rue la Boétie 75008 PARIS

Documents

Sign in to open
Application documents
1 202317033956.pdf 15 May 2023
2 202317033956-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [15-05-2023(online)].pdf 15 May 2023
3 202317033956-STATEMENT OF UNDERTAKING (FORM 3) [15-05-2023(online)].pdf 15 May 2023
4 202317033956-FORM 1 [15-05-2023(online)].pdf 15 May 2023
5 202317033956-DECLARATION OF INVENTORSHIP (FORM 5) [15-05-2023(online)].pdf 15 May 2023
6 202317033956-COMPLETE SPECIFICATION [15-05-2023(online)].pdf 15 May 2023
7 202317033956-FORM-26 [25-07-2023(online)].pdf 25 Jul 2023
8 202317033956-FORM 3 [20-10-2023(online)].pdf 20 Oct 2023
9 202317033956-Proof of Right [26-03-2024(online)].pdf 26 Mar 2024
10 202317033956-FORM 18 [30-09-2024(online)].pdf 30 Sep 2024